Zhejiang Starry Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of pharmaceutical raw materials in China and internationally. Its contrast agent products include X-CT iodine contrast medium, Iohexol, Iopamidol, Iodixanol, Iomeprol, Iopromide, Ioversol, Ioversol hydrolyzate, Iohexol hydrolyzate, Gadobenate dimeglumine, Iodide, Triiodoisophthaloyl chloride, and Ester; and luoroquinolones products, such as Levofloxacin hydrochloride, Levofloxacin, Levofloxacin, and Levofloxacin. The company was founded in 1997 and is headquartered in Taizhou, China.

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Shen, Weiyi

Employees

1,754

Website

www.starrypharm.com

IPO Date

2016-03-09

Headquarters

Modern Industrial Cluster Area, No. 9 West Fengxi Road, Xianju County, Taizhou, Zhejiang Province, 317306, China

Socials

NEWSLETTER

View Data Providers

NEWSLETTER

View Data Providers

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.